284 related articles for article (PubMed ID: 11510758)
1. A family with von Hippel-Lindau disease revealed by pheochromocytoma.
Tomita N; Moriguchi A; Yamasaki K; Taniyama Y; Kotani N; Hashiya N; Yoshida M; Yao M; Higaki J; Ogihara T
Hypertens Res; 2001 Jul; 24(4):445-50. PubMed ID: 11510758
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
3. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
4. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses).
Hes FJ; Feldberg MA
Eur Radiol; 1999; 9(4):598-610. PubMed ID: 10354869
[TBL] [Abstract][Full Text] [Related]
5. [Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis].
Zhang J; Huang YR; Wang JD; Fan XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):5-9. PubMed ID: 14767899
[TBL] [Abstract][Full Text] [Related]
6. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
[TBL] [Abstract][Full Text] [Related]
7. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
[TBL] [Abstract][Full Text] [Related]
8. The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma.
Abbott MA; Nathanson KL; Nightingale S; Maher ER; Greenstein RM
Am J Med Genet A; 2006 Apr; 140(7):685-90. PubMed ID: 16502427
[TBL] [Abstract][Full Text] [Related]
9. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
10. Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.
Vérot PL; Rabattu PY; Chabre O; Gayot A; Sartelet H; Faguet R; Robert Y; Piolat C
Arch Pediatr; 2020 Nov; 27(8):497-501. PubMed ID: 33067065
[TBL] [Abstract][Full Text] [Related]
11. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
[TBL] [Abstract][Full Text] [Related]
12. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
13. Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.
Hasani-Ranjbar S; Amoli MM; Ebrahim-Habibi A; Haghpanah V; Hejazi M; Soltani A; Larijani B
Fam Cancer; 2009; 8(4):465-71. PubMed ID: 19649731
[TBL] [Abstract][Full Text] [Related]
14. Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease.
Hes FJ; Höppener JW; Lips CJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):969-74. PubMed ID: 12629069
[No Abstract] [Full Text] [Related]
15. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
16. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.
Rich TA; Jonasch E; Matin S; Waguespack SG; Gombos DS; Santarpia L; Stolle C; Jimenez C
Cancer Invest; 2008 Jul; 26(6):642-6. PubMed ID: 18584357
[TBL] [Abstract][Full Text] [Related]
17. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
Richard S; Beigelman C; Duclos JM; Fendler JP; Plauchu H; Plouin PF; Resche F; Schlumberger M; Vermesse B; Proye C
Surgery; 1994 Dec; 116(6):1076-81. PubMed ID: 7985090
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report.
Ferragut J; Caimari M; Rituerto B; Gómez-Rivas B; Herrera M; Alonso F
J Pediatr Endocrinol Metab; 1999; 12(4):579-82. PubMed ID: 10417977
[TBL] [Abstract][Full Text] [Related]
20. Early identification of patients with von Hippel-Lindau disease at risk for pheochromocytoma.
Maranchie JK; Walther MM
Curr Urol Rep; 2001 Feb; 2(1):24-30. PubMed ID: 12084291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
